Skip to main content
Figure 5 | BMC Medical Genetics

Figure 5

From: Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib

Figure 5

Cytotoxic effects of patient PBLs on Jurkat cells. The activated PBLs from normal controls (open), Pt 86 (FasL R156G, black), and father of Pt 86 (shaded) were used as the effector cells to mix with Jurkat (target) cells at the E/T ratios shown. Means and error bars of % target cell death are shown, data represent two independent experiments.

Back to article page